Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer

被引:9
|
作者
Li, Roger [1 ]
Spiess, Philippe E. [1 ]
Gilbert, Scott M. [1 ]
Necchi, Andrea [2 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, 12902 USF Magnolia Dr, Tampa, FL 33612 USA
[2] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
关键词
CHEMOTHERAPY;
D O I
10.1016/j.eururo.2019.02.027
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4 / 6
页数:3
相关论文
共 50 条
  • [1] Neoadjuvant therapy for muscle-invasive bladder cancer
    Jain, Rohit K.
    Sonpavde, Guru
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (07) : 603 - 614
  • [2] Zebrafish avatars towards personalized medicine for muscle-invasive bladder cancer
    Sugino, Yusuke
    Bao, Xin
    Sekito, Sho
    Kageyama, Takumi
    Sasaki, Takeshi
    Masui, Satoru
    Nishikawa, Kohei
    Tanaka, Toshio
    Shimada, Yasuhito
    Kato, Manabu
    Takano, Keishi
    Nakayama, Kenji
    Son, Raku
    Murakawa, Yasuhiro
    Inoue, Takahiro
    CANCER SCIENCE, 2025, 116 : 885 - 885
  • [3] Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
    Peyrottes, Arthur
    Ouzaid, Idir
    Califano, Gianluigi
    Hermieu, Jean-Francois
    Xylinas, Evanguelos
    MEDICINA-LITHUANIA, 2021, 57 (08):
  • [4] Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Royce, Trevor J.
    Liu, Yuan
    Milowsky, Matthew, I
    Efstathiou, Jason A.
    Jani, Ashesh B.
    Fischer-Valuck, Benjamin
    Patel, Sagar A.
    CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : 362 - 368
  • [5] Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
    Narayan, Vivek
    Mamtani, Ronac
    Keefe, Stephen
    Guzzo, Thomas
    Malkowicz, S. Bruce
    Vaughn, David J.
    CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1084 - 1091
  • [6] Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Calabro, Fabio
    Sternberg, Cora N.
    EUROPEAN UROLOGY, 2009, 55 (02) : 348 - 358
  • [7] Trimodal therapy for muscle-invasive bladder cancer
    Mathes, Joachim
    Rausch, Steffen
    Todenhoefer, Tilman
    Stenzl, Arnulf
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (12) : 1219 - 1229
  • [8] Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Carvalho, Filipe L. F.
    Zeymo, Alexander
    Egan, Jillian
    Kelly, Colleen H.
    Zheng, Chaoyi
    Lynch, John H.
    Hwang, Jonathan
    Stamatakis, Lambros
    Krasnow, Ross E.
    Kowalczyk, Keith J.
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (04) : 390 - 396
  • [9] Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Lyon, Timothy D.
    Frank, Igor
    Takahashi, Naoki
    Boorjian, Stephen A.
    Moynagh, Michael R.
    Shah, Paras H.
    Tarrell, Robert F.
    Cheville, John C.
    Viers, Boyd R.
    Tollefson, Matthew K.
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : 216 - +
  • [10] Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer
    Macleod, Liam C.
    Fam, Mina M.
    Yabes, Jonathan G.
    Hale, Nathan E.
    Turner, Robert M., II
    Lopa, Samia H.
    Gingrich, Jeffrey R.
    Borza, Tudor
    Skolarus, Ted A.
    Davies, Benjamin J.
    Jacobs, Bruce L.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 201 - +